Brief: Dermapharm Holding SE - Confirms Outlook
Nov 14 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE :
* 9M REVENUE 890.1 EUR MILLION
* 9M ADJUSTED EBITDA AMRGIN 27%
* 9M EBT AT EUR 137.5 MILLION
* 9M UNADJ EBITDA MARGIN 26.3%
* 9M EPS AT EUR 1.73
* 9M OP RESULT EUR 169.1 MILLION
* 9M PROFIT FOR THE PERIOD OF 92.7 MILLION EUR
* 9M PROFIT EUR 92 MILLION
* CONFIRMS OUTLOOK
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit